ID: ALA2312792

Max Phase: Preclinical

Molecular Formula: C52H98O13

Molecular Weight: 931.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCC(CCCCCCCC)CCC(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](COC(=O)CCC(CCCCCCCC)CCCCCCCC)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C52H98O13/c1-5-9-13-17-21-25-29-39(30-26-22-18-14-10-6-2)33-35-43(53)61-37-41-45(55)47(57)49(59)51(63-41)65-52-50(60)48(58)46(56)42(64-52)38-62-44(54)36-34-40(31-27-23-19-15-11-7-3)32-28-24-20-16-12-8-4/h39-42,45-52,55-60H,5-38H2,1-4H3/t41-,42-,45-,46-,47+,48+,49-,50-,51-,52-/m1/s1

Standard InChI Key:  MROBTESPVSUSEJ-BMEIZMHNSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 931.34Molecular Weight (Monoisotopic): 930.7007AlogP: 9.50#Rotatable Bonds: 40
Polar Surface Area: 201.67Molecular Species: NEUTRALHBA: 13HBD: 6
#RO5 Violations: 4HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 11.91CX Basic pKa: CX LogP: 12.38CX LogD: 12.38
Aromatic Rings: 0Heavy Atoms: 65QED Weighted: 0.03Np Likeness Score: 0.76

References

1. Yamamoto H, Oda M, Nakano M, Watanabe N, Yabiku K, Shibutani M, Inoue M, Imagawa H, Nagahama M, Himeno S, Setsu K, Sakurai J, Nishizawa M..  (2013)  Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate.,  56  (1): [PMID:23210481] [10.1021/jm3016443]

Source